https://www.prnewswire.com/news-releases/update-on-phase-3-clinical-trials-of-lanabecestat-for-alzheimers-disease-300664469.html
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca are discontinuing the global Phase 3 clinical trials of lanabecestat, an oral beta...
clinical trialsupdatephaselanabecestatalzheimer